跳至主要内容
临床试验/NCT00884806
NCT00884806已完成不适用

Corneal Staining Evaluation of SiH MPDS FID 114675A

Alcon Research0 个研究点目标入组 110 人开始时间: 2009年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
110
主要终点
Solution-Related Corneal Staining

研究概览

简要总结

The purpose of this study is to clinically evaluate solution-related corneal staining with an investigational multi-purpose disinfecting solution (MPDS) in hydrogel and silicone hydrogel contact lens wearers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18 years of age or older.
  • •Wear contact lenses a minimum of 8 hours per day for at least 7-10 days prior to Visit 1 (screening visit).
  • •Vision correctable to 20/30 (Snellen) or better in each eye at distance with contact lenses at Visit
  • •Must discontinue contact lens wear for at least two consecutive days before Visit 2 (baseline visit).
  • •Other protocol-specified inclusion criteria may apply.

排除标准

  • •Any medical condition (systemic or ophthalmic) that may, in the opinion of the investigator, preclude safe administration of test article or safe participation in the study.
  • •Known sensitivity or intolerance to any protocol-specified contact lens solutions, eye drops, or products containing similar ingredients (e.g., generic products).
  • •Monocular vision (only one eye with functional vision) or fit with only one contact lens.
  • •Use of topical ocular over-the-counter or prescribed topical ocular medication, with the exception of rewetting drops, within 7 days prior to screening visit.
  • •Current or history of ocular infection, inflammation, disease, structural abnormality or conditions within the last 6 months that could affect study participation or may preclude safe administration of the investigational lens care solution, in the opinion of the investigator.
  • •Any corneal surgery, cataract surgery, intraocular lens implants or glaucoma filtering surgery within the last 12 months.
  • •Any slit-lamp finding score of 1 (or rated 3 or 4 for limbal and bulbar conjunctival injection) at screening or baseline visits.
  • •Corneal staining area assessment ≥ 20% in any corneal region in either eye at baseline visit.
  • •Corneal staining graded as 2 (macropunctate) or greater in any corneal region in either eye at baseline visit.
  • •Participation in any investigational clinical study within 30 days of baseline visit.
  • •Other protocol-defined exclusion criteria may apply.

研究组 & 干预措施

FID 114675A

Experimental

FID 114675A used for 7 days, per protocol-specified instructions. Silicone hydrogel or hydrogel contact lenses worn bilaterally on a daily wear basis, one brand only.

干预措施: FID 114675A Multi-Purpose Disinfecting Solution (MPDS) (Device)

FID 114675A

Experimental

FID 114675A used for 7 days, per protocol-specified instructions. Silicone hydrogel or hydrogel contact lenses worn bilaterally on a daily wear basis, one brand only.

干预措施: Etafilcon A contact lens (ACUVUE® 2™) (Device)

FID 114675A

Experimental

FID 114675A used for 7 days, per protocol-specified instructions. Silicone hydrogel or hydrogel contact lenses worn bilaterally on a daily wear basis, one brand only.

干预措施: Senofilcon A contact lens (ACUVUE® OASYS™) (Device)

FID 114675A

Experimental

FID 114675A used for 7 days, per protocol-specified instructions. Silicone hydrogel or hydrogel contact lenses worn bilaterally on a daily wear basis, one brand only.

干预措施: Lotrafilcon B contact lens (O2 OPTIX®) (Device)

FID 114675A

Experimental

FID 114675A used for 7 days, per protocol-specified instructions. Silicone hydrogel or hydrogel contact lenses worn bilaterally on a daily wear basis, one brand only.

干预措施: Balafilcon A contact lens (PureVision®) (Device)

结局指标

主要结局

Solution-Related Corneal Staining

时间窗: Day 7

Corneal staining was assessed by the investigator using fluorescein dye, a yellow filter, and a slit lamp. Corneal staining was graded on a continuous scale of 0% (no staining in the region) to 100% (staining covers entire region) in 1% increments for 5 corneal regions (central, nasal, temporal, inferior, and superior). Solution-related corneal staining was defined as ≥20% corneal staining area in at least 3 corneal regions of both eyes.

次要结局

  • Mean Lens Comfort(Day 7)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验